GPT Healthcare Limited (GPTHEALTH)
Please find enclosed press release on UFR for Q1FY2027
Press Release - Q1FY27
- Total Income 128.2bn +18.0% y-y; EBITDA 26.2bn +38.5% y-y (margin 20.4%, +300 bps y-y); PAT 12.7bn +65.7% y-y
- Occupancy improved to 58.07% excluding new Raipur facility; overall 45.5% including Raipur
- Raipur hospital received liver transplant license; expected breakeven by Q3 FY27
- Jamshedpur hospital on track for completion by Q4 FY27
- Expansion focused on high-value specialties and robotic-assisted procedures
- Chairman: "Capital-efficient expansion to increase capacity to over 1,000 beds; net-debt-free position maintained"
Source: Original filing PDF
—
view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts
BOT
🚨 GPTHEALTH — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add GPTHEALTH to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
More on GPT Healthcare Limited
Important.
The summary above is generated automatically from GPT Healthcare Limited's own
public regulatory filing under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment Adviser.
This page is informational, not investment advice, a recommendation to buy
or sell any security, or any opinion about the company's business, governance
or financial health. Always read the original filing before acting and consult
a registered adviser for investment decisions.